Vivien Brown (MDCM, CCFP, FCFP, NCMP) Assistant Professor, Department of Family & Community Medicine University of Toronto Toronto, ON
|
Dr. Brown received honoraria and had consulting roles, as well as served on advisory boards and as a speaker for MD Briefcase, Meducom, The Rounds, Antibody, STA Communications, Immunize Canada, Women’s Brain Health Initiative, Amgen, Allergan, Bayer, Biosyent, GSK Merck, Novo Nordisk, Novartis, Pfizer, Sunovion, and Searchlight.
|
Jeffrey Habert (MD, CCFP, FCFP) Assistant Professor, Department of Family & Community Medicine University of Toronto Toronto, ON
|
Dr. Habert received honoraria and had consulting roles, as well as served on advisory boards and as a speaker for CPD Network Association, Allergan, Alliance, Academy, Amgen, Antibody, AstraZeneca, BMS, Bayer, Boehringer Ingelheim, Brandaide, Bridge, CHRC, CTA, CCRN, Eisai, Eli Lilly, Four Health Comm, Janssen, Lundbeck, liV, Master Clinician, Meducom, MedPlan, MD Briefcase, Novartis, Novo Nordisk, Otsuka, Pfizer, Purdue, Sunovion, Servier, and STA Communications.
|
Algis Jovaisas (MD, FRCPC) Adjunct Professor of Medicine, Department of Medicine University of Ottawa Ottawa, ON
|
Dr. Jovaisas received research funding, honoraria, as well as served on advisory boards and as a speaker, and had consulting roles for Amgen, Pfizer, Novartis, Sandoz, Eli Lilly, MSD, Gilead, and AbbVie.
|
Daniel Ngui (BScPT, MD, FCFP) Clinical Professor, Department of Family Medicine University of British Columbia Vancouver, BC
|
Dr. Ngui received research funding, honoraria, as well as served on advisory boards, consult meetings and as a speaker, and had consulting roles for Amgen, AstraZeneca, BMS, BI, Lilly, Novo Nordisk, Simple Trial, Amgen 20170191 trial, IHE eCare CV Risk, CHRC EMR Registry Trials: AF OAC, Advantage CV, Advantage OP, and Pioneer REAL.
|